Nikolaou M, Theodorakis N, Feretzakis G et al (2024) Nationwide mortality trends from 2001 to 2020 in Greece: health policy implications under the scope of aging societies. Hellenic J Cardiol 28(24):00177–5. https://doi.org/10.1016/j.hjc.2024.08.009

Article  Google Scholar 

Theodorakis N, Feretzakis G, Vamvakou G, Verykios VS, Polymeris A, Nikolaou M (2024) Testosterone therapy for functional hypogonadism in middle-aged and elderly males: current evidence and future perspectives. Hormones (Athens). https://doi.org/10.1007/s42000-024-00587-2

Article  PubMed  Google Scholar 

Hartupee J, Mann DL (2017) Neurohormonal activation in heart failure with reduced ejection fraction. Nat Rev Cardiol 14(1):30–38. https://doi.org/10.1038/nrcardio.2016.163

Article  PubMed  CAS  Google Scholar 

Xie Y, Wei Y, Li D, Pu J, Ding H, Zhang X (2023) Mechanisms of SGLT2 inhibitors in heart failure and their clinical value. J Cardiovasc Pharmacol 81(1):4–14. https://doi.org/10.1097/FJC.0000000000001380

Article  PubMed  CAS  Google Scholar 

Kosiborod MN, Abildstrøm SZ, Borlaug BA, Butler J et al (2023) Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med 389(12):1069–1084. https://doi.org/10.1056/NEJMoa2306963

Article  PubMed  CAS  Google Scholar 

Cittadini A, Salzano A, Iacoviello M et al (2021) Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.C.A. Registry. Eur J Prev Cardiol 28(15):1691–1700. https://doi.org/10.1093/eurjpc/zwab020

Article  PubMed  Google Scholar 

Lincoff AM, Bhasin S, Flevaris P et al (2023) Cardiovascular safety of testosterone-replacement therapy. N Engl J Med 389(2):107–117. https://doi.org/10.1056/NEJMoa2215025

Article  PubMed  CAS  Google Scholar 

Navarro-Peñalver M, Perez-Martinez MT, Gómez-Bueno M et al (2018) Testosterone replacement therapy in deficient patients with chronic heart failure: a randomized double-blind controlled pilot study. J Cardiovasc Pharmacol Ther 23(6):543–550. https://doi.org/10.1177/1074248418784020

Article  PubMed  CAS  Google Scholar 

Dos Santos MR, Sayegh AL, Bacurau AV et al (2016) Effect of exercise training and testosterone replacement on skeletal muscle wasting in patients with heart failure with testosterone deficiency. Mayo Clin Proc 91(5):575–586. https://doi.org/10.1016/j.mayocp.2016.02.014

Article  PubMed  CAS  Google Scholar 

Malkin CJ, Pugh PJ, West JN et al (2006) Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur Heart J 27(1):57–64. https://doi.org/10.1093/eurheartj/ehi443

Article  PubMed  CAS  Google Scholar 

Iellamo F, Volterrani M, Caminiti G et al (2010) Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. J Am Coll Cardiol 56(16):1310–1316. https://doi.org/10.1016/j.jacc.2010.03.090

Article  PubMed  CAS  Google Scholar 

Stout M, Tew GA, Doll H et al (2012) Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study. Am Heart J 164(6):893–901. https://doi.org/10.1016/j.ahj.2012.09.016

Article  PubMed  CAS  Google Scholar 

Malkin CJ, Morris PD, Pugh PJ et al (2003) Effect of testosterone therapy on QT dispersion in men with heart failure. Am J Cardiol 92(10):1241–1243. https://doi.org/10.1016/j.amjcard.2003.07.044

Article  PubMed  CAS  Google Scholar 

Schwartz JB, Volterrani M, Caminiti G et al (2011) Effects of testosterone on the Q-T interval in older men and older women with chronic heart failure. Int J Androl 34(5 Pt 2). https://doi.org/10.1111/j.1365-2605.2011.01163.x

Caminiti G, Volterrani M, Iellamo F et al (2009) Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 54(10):919–927. https://doi.org/10.1016/j.jacc.2009.04.078

Article  PubMed  CAS  Google Scholar 

Pugh PJ, Jones RD, West JN et al (2004) Testosterone treatment for men with chronic heart failure. Heart 90(4):446–447. https://doi.org/10.1136/hrt.2003.014639

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mirdamadi A, Garakyaraghi M, Pourmoghaddas A et al (2014) Beneficial effects of testosterone therapy on functional capacity, cardiovascular parameters, and quality of life in patients with congestive heart failure. Biomed Res Int 2014:392432. https://doi.org/10.1155/2014/392432

Article  PubMed  PubMed Central  CAS  Google Scholar 

Malkin CJ, Jones TH, Channer KS (2007) The effect of testosterone on insulin sensitivity in men with heart failure. Eur J Heart Fail 9(1):44–50. https://doi.org/10.1016/j.ejheart.2006.04.006

Article  PubMed  CAS  Google Scholar 

Pugh PJ, Jones RD, Malkin CJ et al (2005) Physiologic testosterone therapy has no effect on serum levels of tumour necrosis factor-alpha in men with chronic heart failure. Endocr Res 31(4):271–283. https://doi.org/10.1080/07435800500406205

Article  PubMed  CAS  Google Scholar 

Theodorakis N, Feretzakis G, Kreouzi M, Anagnostou D, Hitas C, Verykios VS, Nikolaou M (2024) Growth hormone therapy in chronic heart failure: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgae814

Article  PubMed Central  Google Scholar 

Theodorakis N, Kreouzi M, Hitas C, Anagnostou D, Nikolaou M (2024) Growth hormone and heart failure: implications for patient stratification, prognosis, and precision medicine. Diagnostics 14(24):2831. https://doi.org/10.3390/diagnostics14242831

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shi C, Bao Y, Chen X, Tian L (2022) The effectiveness of thyroid hormone replacement therapy on heart failure and low-triiodothyronine syndrome: an updated systematic review and meta-analysis of randomized controlled trials. Endocr Pract 28(11):1178–1186. https://doi.org/10.1016/j.eprac.2022.07.004

Article  PubMed  Google Scholar 

Theodorakis N, Feretzakis G, Kreouzi M et al (2025) Ghrelin: an emerging therapy for heart failure. Clin Endocrinol (Oxf). https://doi.org/10.1111/cen.15196

Article  PubMed  Google Scholar 

Dhar M, Mittal K, Parchani A, Sharma M, Bahurupi Y, Kalra S, Bhat NK (2022) Adjuvant testosterone therapy in chronic heart failure (ATTIC): a randomised open-label trial. BMJ Open 12(5):e056994. https://doi.org/10.1136/bmjopen-2021-056994

Article  PubMed  PubMed Central  Google Scholar 

Theodorakis N, Nikolaou M (2025) Integrated management of cardiovascular-renal-hepatic-metabolic syndrome: expanding roles of SGLT2is, GLP-1RAs, and GIP/GLP-1RAs. Biomedicines 13(1):135. https://doi.org/10.3390/biomedicines13010135

Article  PubMed  PubMed Central  CAS  Google Scholar 

Theodorakis N, Kreouzi M, Hitas C, Anagnostou D, Nikolaou M (2024) Adipokines and cardiometabolic heart failure with preserved ejection fraction: a state-of-the-art review. Diagnostics 14(23):2677. https://doi.org/10.3390/diagnostics14232677

Article  PubMed  PubMed Central  CAS  Google Scholar